Key result
Emergency splenectomy and adjuvant chemotherapy achieved 18 months of recurrence-free survival in a 42-year-old man presenting with a ruptured primary splenic angiosarcoma.
Splenectomy followed by adjuvant chemotherapy with epirubicin and ifosfamide may provide long-term recurrence-free survival in patients with spontaneously ruptured splenic angiosarcoma.
Answers are grounded in this paper and cite their sources.
Supports splenectomy plus chemotherapy in ruptured splenic angiosarcoma; hypothesis-generating and should not yet change practice.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Yamamoto et al. (2014) studied this question. Emergency splenectomy and adjuvant chemotherapy achieved 18 months of recurrence-free survival in a 42-year-old man presenting with a ruptured primary splenic angiosarcoma.
Synapse has enriched 10 related papers. Consider them for comparative context: